Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Performances in N.Y.C. Advertisement Supported by Elim Chan has been named the symphony’s next music director. She joins a small field of female conductors at American orchestras, as San Francisco ...

The jury in the trial of Andrew Left was presented with dueling portraits of the short-seller on Thursday: one, a law-breaking schemer, and the other, a clever trader just doing his job. That's how ...

The San Francisco Symphony announced on Thursday Elim Chan will serve as the first female music director in the orchestra’s history. She starts in September 2027 and will lead the orchestra in a ...

Hong Kong-born conductor Elim Chan has been named music director designate of the San Francisco Symphony, capping months of intense industry speculation over her next permanent posting. The orchestra ...

A federal prosecutor urged jurors to convict prominent short seller Andrew Left of securities fraud because “overwhelming evidence” at the trial showed he’d rigged the market for years to reap ...

Conductor Elim Chan will become the 13th music director in San Francisco Symphony’s 115-year history when she assumes the post for the 2027-28 season. The company announced Thursday that the ...

That sound of breaking glass? It’s Hong Kong-born conductor Elim Chan, 39, shattering a particularly stubborn ceiling after being named the first woman to lead the San Francisco Symphony in its ...